• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Rapid HIV-RNA decline following addition of raltegravir and tenofovir to ongoing highly active antiretroviral therapy in a woman presenting with high-level HIV viraemia at week 38 of pregnancy.

作者信息

Pinnetti Carmela, Baroncelli Silvia, Villani Paola, Fantoni Massimo, Tozzi Valerio, De Luca Andrea, Cauda Roberto, Anzidei Gianfranco, Cusato Maria, Regazzi Mario, Floridia Marco, Tamburrini Enrica

出版信息

J Antimicrob Chemother. 2010 Sep;65(9):2050-2. doi: 10.1093/jac/dkq264. Epub 2010 Jul 14.

DOI:10.1093/jac/dkq264
PMID:20630894
Abstract
摘要

相似文献

1
Rapid HIV-RNA decline following addition of raltegravir and tenofovir to ongoing highly active antiretroviral therapy in a woman presenting with high-level HIV viraemia at week 38 of pregnancy.在一名怀孕38周时出现高水平HIV病毒血症的女性中，在持续的高效抗逆转录病毒治疗基础上加用拉替拉韦和替诺福韦后，HIV-RNA迅速下降。
J Antimicrob Chemother. 2010 Sep;65(9):2050-2. doi: 10.1093/jac/dkq264. Epub 2010 Jul 14.
2
Risk of early virological failure of once-daily tenofovir-emtricitabine plus twice-daily nevirapine in antiretroviral therapy-naive HIV-infected patients.初治的HIV感染患者接受每日一次替诺福韦-恩曲他滨加每日两次奈韦拉平抗逆转录病毒治疗时早期病毒学失败的风险。
Clin Infect Dis. 2008 Apr 1;46(7):1127-9. doi: 10.1086/529394.
3
No residual activity of raltegravir after development of 148 complex mutations in vivo.在体内出现148种复合突变后，拉替拉韦无残留活性。
J Int Assoc Physicians AIDS Care (Chic). 2008 Nov-Dec;7(6):281-2. doi: 10.1177/1545109708327489.
4
Tenofovir-based rescue therapy for advanced liver disease in 6 patients coinfected with HIV and hepatitis B virus and receiving lamivudine.对6例合并感染HIV和乙肝病毒且正在接受拉米夫定治疗的晚期肝病患者采用基于替诺福韦的挽救疗法。
Clin Infect Dis. 2008 Feb 1;46(3):e28-30. doi: 10.1086/525857.
5
Impact of tenofovir-containing antiretroviral therapy on chronic hepatitis B in a cohort co-infected with human immunodeficiency virus.含替诺福韦的抗逆转录病毒疗法对人类免疫缺陷病毒合并感染队列中慢性乙型肝炎的影响。
J Antimicrob Chemother. 2005 Dec;56(6):1087-93. doi: 10.1093/jac/dki396. Epub 2005 Nov 3.
6
Once-daily treatment with saquinavir mesylate (2000 mg) and ritonavir (100 mg) together with a fixed-dose combination of abacavir/lamivudine (600/300 mg) or tenofovir/emtricitabine (245/200 mg) in HIV-1-infected patients.在感染 HIV-1 的患者中，每日一次给予硫酸茚地那韦（2000 毫克）和利托那韦（100 毫克），并与阿巴卡韦/拉米夫定（600/300 毫克）或替诺福韦/恩曲他滨（245/200 毫克）的固定剂量组合联合使用。
J Antimicrob Chemother. 2009 Dec;64(6):1260-4. doi: 10.1093/jac/dkp348. Epub 2009 Sep 22.
7
Raltegravir: is a 400 mg once-daily dose enough?拉替拉韦：每日一次400毫克的剂量足够吗？
J Antimicrob Chemother. 2010 Mar;65(3):595-7. doi: 10.1093/jac/dkp488. Epub 2010 Jan 12.
8
Initial results reported on raltegravir once-daily dosing.已报道了拉替拉韦每日一次给药的初步结果。
AIDS Patient Care STDS. 2011 Feb;25(2):123.
9
Efficacy and safety of tenofovir double-dose in treatment-experienced HIV-infected patients: the TENOPLUS study.替诺福韦双倍剂量用于经治HIV感染患者的疗效与安全性：TENOPLUS研究
J Med Virol. 2007 Feb;79(2):105-10. doi: 10.1002/jmv.20769.
10
Metabolic benefits of switching to tenofovir/lamivudine after long-term use of stavudine/lamivudine in NNRTI-based antiretroviral regimens: a prospective study.在基于非核苷类逆转录酶抑制剂的抗逆转录病毒治疗方案中，长期使用司他夫定/拉米夫定后换用替诺福韦/拉米夫定的代谢益处：一项前瞻性研究。
J Infect. 2011 May;62(5):406-9. doi: 10.1016/j.jinf.2011.02.012. Epub 2011 Mar 5.

引用本文的文献

1
Thai national guidelines for the prevention of mother-to-child transmission of human immunodeficiency virus 2017.《2017年泰国预防人类免疫缺陷病毒母婴传播国家指南》
Asian Biomed (Res Rev News). 2017 Apr;11(2):145-159. doi: 10.5372/1905-7415.1102.547.
2
A Single-Center Retrospective Cohort Analysis of Maternal and Infant Outcomes in HIV-Infected Mothers Treated with Integrase Inhibitors During Pregnancy.一项关于孕期接受整合酶抑制剂治疗的HIV感染母亲母婴结局的单中心回顾性队列分析。
Infect Dis Ther. 2017 Dec;6(4):531-544. doi: 10.1007/s40121-017-0170-1. Epub 2017 Sep 13.
3
Integrase inhibitors in late pregnancy and rapid HIV viral load reduction.
妊娠晚期的整合酶抑制剂与HIV病毒载量的快速降低
Am J Obstet Gynecol. 2016 Mar;214(3):385.e1-7. doi: 10.1016/j.ajog.2015.12.052.
4
Bidirectional Transfer of Raltegravir in an Ex Vivo Human Cotyledon Perfusion Model.雷特格韦在体外人胎盘小叶灌注模型中的双向转运
Antimicrob Agents Chemother. 2016 Apr 22;60(5):3112-4. doi: 10.1128/AAC.00007-16. Print 2016 May.
5
A case series of third-trimester raltegravir initiation: Impact on maternal HIV-1 viral load and obstetrical outcomes.孕晚期开始使用雷特格韦的病例系列研究：对孕产妇HIV-1病毒载量及产科结局的影响。
Can J Infect Dis Med Microbiol. 2015 May-Jun;26(3):145-50. doi: 10.1155/2015/731043.
6
Raltegravir pharmacokinetics during pregnancy.孕期拉替拉韦的药代动力学。
J Acquir Immune Defic Syndr. 2014 Dec 1;67(4):375-81. doi: 10.1097/QAI.0000000000000318.
7
Micronucleated erythrocytes in newborn rats exposed to raltegravir placental transfer.暴露于拉替拉韦胎盘转运的新生大鼠中的微核红细胞。
Biomed Res Int. 2014;2014:851820. doi: 10.1155/2014/851820. Epub 2014 May 25.
8
Raltegravir for HIV-1 infected children and adolescents: efficacy, safety, and pharmacokinetics.雷特格韦用于HIV-1感染儿童和青少年：疗效、安全性及药代动力学
Adolesc Health Med Ther. 2013 Aug 27;4:79-87. doi: 10.2147/AHMT.S29462. eCollection 2013.
9
Short communication: Use of raltegravir in late-presenting HIV-infected pregnant women.简短通讯：雷特格韦在晚期就诊的HIV感染孕妇中的应用
AIDS Res Hum Retroviruses. 2013 Nov;29(11):1451-4. doi: 10.1089/AID.2013.0059. Epub 2013 Jun 25.
10
Pharmacokinetic optimization of antiretroviral therapy in pregnancy.妊娠抗逆转录病毒治疗的药代动力学优化。
Clin Pharmacokinet. 2012 Oct 1;51(10):639-59. doi: 10.1007/s40262-012-0002-0.